Aadi Bioscience Announces Publication of its Phase 2 Registrational (AMPECT) Trial of nab-Sirolimus in Patients with Malignant Perivascular Epithelioid Cell Tumors in the Journal of Clinical Oncology
Stock Information for Aadi Bioscience Inc.
Loading
Please wait while we load your information from QuoteMedia.